findmyKOL

Geetha Soodini, MD

Basic profile

Joslin Diabetes Center

ORCIDNone on fileNPI
RegionCumming, GA · SoutheastSpecialtyEndocrinology, Diabetes & MetabolismFocusEndocrinology/Metabolic
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2009Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Geetha Soodini is an Endocrinology/Metabolic physician affiliated with Joslin Diabetes Center. OpenAlex indexes 9 publications with 252 citations (h-index 5).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
9publications

Distinct works indexed by OpenAlex.

252citations

Total citations across indexed works.

5h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
52companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

1505 Northside Blvd
Suite 2800
Cumming, GA 30041

Telephone

770-886-3842

Provider last certified this registry record 26 Feb 2021.

View the NPPES registry record

Industry payments

52 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Musculoskeletal

    60.4%
    RANK Ligand Inhibitor60.4%
    Denosumab100%
    Part B, office-administered43 patients
  • Metabolism & gastrointestinal

    17.4%
    GLP-1 receptor agonist6.5%
    Ozempic60%Mounjaro32%Trulicity9%
    Part D63 patients
    Insulin Analog4.3%
    Tresiba Flextouch U-10022%Toujeo Solostar13%Novolog Flexpen12%Lantus Solostar12%Fiasp Flextouch9%Novolog8%Tresiba Flextouch U-2007%Basaglar Kwikpen U-1007%Toujeo Max Solostar6%Lyumjev Kwikpen U-1004%
    Part D<11 patients

    + 5 more classes in this area

  • Hormonal (systemic)

    16.8%
    l-Thyroxine12.3%
    Levothyroxine Sodium55%Synthroid36%Levoxyl4%Unithroid4%Euthyrox2%
    Part D<11 patients
    l-Triiodothyronine2.2%
    Liothyronine Sodium100%
    Part D50 patients

    + 4 more classes in this area

Where care is delivered (Part B)0% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”